This is a Phase III study in patients with melanoma that has spread to the lymph nodes and/or a distant organ, and who have had all of their cancer surgically removed. The purpose of this study is to evaluate the ability of the CancerVax™ vaccine to prevent or slow the recurrence of melanoma.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
670
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Arizona Cancer Center
Tucson, Arizona, United States
Central Arkansas Veterans Healthcare System
Little Rock, Arkansas, United States
University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
Kaiser Permanente Medical Group
Anaheim, California, United States
Cedars Sinai Comprehensive Cancer Center
Los Angeles, California, United States
Hoag Memorial Hospital Presbyterian
Newport Beach, California, United States
Comprehensive Cancer Center at DRMC
Palm Springs, California, United States
Kaiser Permanente Medical Group
Riverside, California, United States
Kaiser Permanente Medical Group
San Diego, California, United States
Sharp Hospital
San Diego, California, United States
...and 67 more locations